Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
94M
-
Shares change
-
+1.75M
-
Total reported value, excl. options
-
$833M
-
Value change
-
+$10.2M
-
Put/Call ratio
-
0.19
-
Number of buys
-
114
-
Number of sells
-
-103
-
Price
-
$8.87
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2025
256 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q1 2025.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94M shares
.
Largest 10 shareholders include BlackRock, Inc. (15.5M shares), VANGUARD GROUP INC (10.7M shares), STATE STREET CORP (5.27M shares), DISCIPLINED GROWTH INVESTORS INC /MN (4.73M shares), WELLINGTON MANAGEMENT GROUP LLP (4.59M shares), MILLENNIUM MANAGEMENT LLC (4.07M shares), EARNEST PARTNERS LLC (3.98M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (3.9M shares), BANK OF AMERICA CORP /DE/ (2.63M shares), and D. E. Shaw & Co., Inc. (2.52M shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.